BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24550395)

  • 1. Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization.
    Cerutti N; Killick M; Jugnarain V; Papathanasopoulos M; Capovilla A
    J Biol Chem; 2014 Apr; 289(15):10455-10465. PubMed ID: 24550395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange.
    Cerutti N; Mendelow BV; Napier GB; Papathanasopoulos MA; Killick M; Khati M; Stevens W; Capovilla A
    J Biol Chem; 2010 Aug; 285(33):25743-52. PubMed ID: 20538591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox exchange of the disulfides of human two-domain CD4 regulates the conformational dynamics of each domain, providing insight into its mechanisms of control.
    Owen GR; Le D; Stoychev S; Cerutti NM; Papathanasopoulos M
    Biochem Biophys Res Commun; 2018 Mar; 497(2):811-817. PubMed ID: 29470989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin.
    Azimi I; Matthias LJ; Center RJ; Wong JW; Hogg PJ
    J Biol Chem; 2010 Dec; 285(51):40072-80. PubMed ID: 20943653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion.
    Barbouche R; Miquelis R; Jones IM; Fenouillet E
    J Biol Chem; 2003 Jan; 278(5):3131-6. PubMed ID: 12218052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120.
    Reiser K; François KO; Schols D; Bergman T; Jörnvall H; Balzarini J; Karlsson A; Lundberg M
    Int J Biochem Cell Biol; 2012 Mar; 44(3):556-62. PubMed ID: 22230366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoprotein.
    Kassa A; Dey AK; Sarkar P; Labranche C; Go EP; Clark DF; Sun Y; Nandi A; Hartog K; Desaire H; Montefiori D; Carfi A; Srivastava IK; Barnett SW
    PLoS One; 2013; 8(10):e76139. PubMed ID: 24146829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
    Alsahafi N; Debbeche O; Sodroski J; Finzi A
    PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
    J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD4 Metastability Is a Function of the Allosteric Disulfide Bond in Domain 2.
    Owen GR; Channell JA; Forsyth VT; Haertlein M; Mitchell EP; Capovilla A; Papathanasopoulos M; Cerutti NM
    Biochemistry; 2016 Apr; 55(15):2227-37. PubMed ID: 27009680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lineage-specific differences between human and simian immunodeficiency virus regulation of gp120 trimer association and CD4 binding.
    Finzi A; Pacheco B; Xiang SH; Pancera M; Herschhorn A; Wang L; Zeng X; Desormeaux A; Kwong PD; Sodroski J
    J Virol; 2012 Sep; 86(17):8974-86. PubMed ID: 22696649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry.
    Gallina A; Hanley TM; Mandel R; Trahey M; Broder CC; Viglianti GA; Ryser HJ
    J Biol Chem; 2002 Dec; 277(52):50579-88. PubMed ID: 12218051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.
    Crublet E; Andrieu JP; Vivès RR; Lortat-Jacob H
    J Biol Chem; 2008 May; 283(22):15193-200. PubMed ID: 18378683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
    Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the thioredoxin system by PX-12 (1-methylpropyl 2-imidazolyl disulfide) impedes HIV-1 infection in TZM-bl cells.
    Lundberg M; Mattsson Å; Reiser K; Holmgren A; Curbo S
    Sci Rep; 2019 Apr; 9(1):5656. PubMed ID: 30948772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands.
    Lu M; Ma X; Reichard N; Terry DS; Arthos J; Smith AB; Sodroski JG; Blanchard SC; Mothes W
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32522853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate.
    Staropoli I; Chanel C; Girard M; Altmeyer R
    J Biol Chem; 2000 Nov; 275(45):35137-45. PubMed ID: 10926931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
    Anang S; Richard J; Bourassa C; Goyette G; Chiu TJ; Chen HC; Smith AB; Madani N; Finzi A; Sodroski J
    J Virol; 2022 Sep; 96(17):e0063622. PubMed ID: 35980207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.